State-of-the-art MR Imaging for Thoracic Diseases
Magn Reson Med Sci. 2021 Apr 29. doi: 10.2463/mrms.rev.2020-0184. Online ahead of print.ABSTRACTSince thoracic MR imaging was first used in a clinical setting, it has been suggested that MR imaging has limited clinical utility for thoracic diseases, especially lung diseases, in comparison with x-ray CT and positron emission tomography (PET)/CT. However, in many countries and states and for specific indications, MR imaging has recently become practicable. In addition, recently developed pulmonary MR imaging with ultra-short TE (UTE) and zero TE (ZTE) has enhanced the utility of MR imaging for thoracic diseases in routine clinical practice. Furthermore, MR imaging has been introduced as being capable of assessing pulmonary function. It should be borne in mind, however, that these applications have so far been academically and clinically used only for healthy volunteers, but not for patients with various pulmonary diseases in Japan or other countries. In 2020, the Fleischner Society published a new report, which provides consensus expert opinions regarding appropriate clinical indications of pulmonary MR imaging for not only oncologic but also pulmonary diseases. This review article presents a brief history of MR imaging for thoracic diseases regarding its technical aspects and major clinical indications in Japan 1) in terms of what is currently available, 2) promising but requiring further validation or evaluation, and 3) developments warranting research investigations in precl...
Source: Magnetic Resonance in Medical Sciences : MRMS - Category: Radiology Authors: Yumi Tanaka Yoshiharu Ohno Satomu Hanamatsu Yuki Obama Takahiro Ueda Hirotaka Ikeda Akiyoshi Iwase Takashi Fukuba Hidekazu Hattori Kazuhiro Murayama Takeshi Yoshikawa Daisuke Takenaka Hisanobu Koyama Hiroshi Toyama Source Type: research
More News: American Health | Cancer & Oncology | Japan Health | Obama | PET Scan | Radiology | Study | USA Health